Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Role of Receptor Interacting Protein (RIP) kinases in cancer

Genes & Diseases(2021)10.1016/j.gendis.2021.10.007Source: DataRank Database

Role of Receptor Interacting Protein (RIP) kinases in cancer is a research paper published in Genes & Diseases (2021). On theSindex it has a DataRank of 0. It has been cited 29 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access29 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (17 grants)Impact (FWCI 1.57)OA: goldTopics (23)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Jian Yu ORCID,Lin Zhang ORCID,Kaylee Ermine ORCID

Live enrichment

PubMed:36157481 OpenAlex:https://openalex.org/W3215509516

National Institutes of Health

Grant: P30CA047904

National Institutes of Health

Grant: R01CA203028

National Institutes of Health

Grant: R01CA215481

National Institutes of Health

Grant: R01CA217141

National Institutes of Health

Grant: R01CA236271

National Institutes of Health

Grant: R01CA247231

National Institutes of Health

Grant: R01CA248112

National Institutes of Health

Grant: T32GM133332

National Institutes of Health

Grant: 1R01CA248112-01A1

BET degraders for improving colorectal cancer therapy

National Institutes of Health

Grant: 7R01CA247231-05

Targeting defective necroptosis in colorectal cancer

National Institutes of Health

Grant: 1T32GM133332-01A1

Predoctoral Training in Pharmacological Sciences (Resubmission)

National Institutes of Health

Grant: 5R01CA217141-04

Novel Mcl-1 inhibitors for overcoming therapeutic resistance in colorectal cancer

National Institutes of Health

Grant: 5R01CA215481-04

Translation addiction and targeting in colon cancer

National Institutes of Health

Grant: 3P30CA047904-07S1

CANCER CENTER SUPPORT GRANT

National Institutes of Health

Grant: 5R01CA236271-02

Role of necroptosis in colorectal cancer therapy

National Institutes of Health

Grant: 5R01CA203028-03

Role of Mcl-1 degradation in colorecal cancer therapy

NIGMS NIH HHS

Grant: T32 GM008424

FWCI

1.57

Citation Percentile

0.8%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.gendis.2021.10.007

publisherhttps://doi.org/10.1016/j.gendis.2021.10.007

publisherhttps://api.elsevier.com/content/article/PII:S2352304221001240?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2352304221001240?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36157481

Fields of Study

Cell death mechanisms and regulationinterferon and immune responsesNF-κB Signaling Pathways0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

KinaseNecroptosisBiologyCancerCancer researchSignal transductionCell biologyProgrammed cell deathApoptosisGeneticsCell deathMedicine (General)Review ArticleQH426-470R5-920RIP kinasesImmune response

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being